Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inflammation and Daily Life Study
NCT03771612Phase 1Completed
- Sponsor
- University of California, Los Angeles
- Start
- Feb 2022
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in inflammation comparing Naproxen with Placebo (2 arms). Primary endpoints: Loneliness at 2 weeks, Negative Picture Viewing Task at 2 weeks and 1 more. Started Feb 2022; status: completed.
02
Drugs
naproxen
03
Conditions
inflammation
Beyond the preview
Go deeper on NCT03771612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03771612.